Table 6.
Most common phenotypes among multiply‐resistant isolates (n = 152)
| Frequency of Resistance Phenotypea | % (95% CI)b | Phenotype |
|---|---|---|
| 80 | 47.1 (39.7–54.5) | Kanamycin, Streptomycin |
| 11 | 6.5 (3.6–11.4) | Ampicillin, Amoxicillin‐Clavulanate |
| 8 | 4.7 (2.3–9.2) | Kanamycin, Streptomycin, Tetracycline |
| 8 | 4.7 (2.3–9.2) | Ampicillin‐Clavulanate, Tetracycline |
| 7 | 4.1 (1.9–8.5) | Spectinomycin, Danofloxacin |
| 7 | 4.1 (1.9–8.5) | Spectinomycin, Danofloxacin, Tetracycline |
| 6 | 3.5 (1.5–7.7) | Kanamycin, Streptomycin, Ampicillin‐Clavulanate |
| 25 | 16.4 (10.5–22.4) | 25 other multiply‐resistant phenotypes |
a
From a total of 32 multiply‐resistance phenotypes; the phenotypes listed had a frequency of >2% among multiply‐resistant M. haemolytica isolates.
b
Adjusted CI for binomial proportions (adding 2 successes and 2 failures) were estimated as previously described.9